Prabhala Rao H, Neri Paola, Bae Jooeun E, Tassone Pierfrancesco, Shammas Masood A, Allam Charles K, Daley John F, Chauhan Dharminder, Blanchard Elizabeth, Thatte Hemant S, Anderson Kenneth C, Munshi Nikhil C
Veterans Administration Boston Healthcare System, Harvard Medical School, Boston, MA, USA.
Blood. 2006 Jan 1;107(1):301-4. doi: 10.1182/blood-2005-08-3101. Epub 2005 Sep 8.
Multiple myeloma (MM) is characterized by the production of monoclonal immunoglobulin and is associated with suppressed uninvolved immunoglobulins and dysfunctional T-cell responses. The biologic basis of this dysfunction remains ill defined. Because T regulatory (T(reg)) cells play an important role in suppressing normal immune responses, we evaluated the potential role of T(reg) cells in immune dysfunction in MM. We observed a significant increase in CD4+ CD25+ T cells in patients with monoclonal gammopathy of undetermined significance (MGUS) and in patients with MM compared with healthy donors (25% and 26%, respectively, vs 14%); however, T(reg) cells as measured by FOXP3 expression are significantly decreased in patients with MGUS and MM compared with healthy donors. Moreover, even when they are added in higher proportions, T(reg) cells in patients with MM and MGUS are unable to suppress anti-CD3-mediated T-cell proliferation. This decreased number and function of T(reg) cells in MGUS and in MM may account, at least in part, for the nonspecific increase in CD4+ CD25+ T cells, thereby contributing to dysfunctional T-cell responses.
多发性骨髓瘤(MM)的特征是产生单克隆免疫球蛋白,并与未受累免疫球蛋白的抑制及功能失调的T细胞反应相关。这种功能失调的生物学基础仍不清楚。由于调节性T(T(reg))细胞在抑制正常免疫反应中起重要作用,我们评估了T(reg)细胞在MM免疫功能失调中的潜在作用。我们观察到,意义未明的单克隆丙种球蛋白病(MGUS)患者和MM患者的CD4+ CD25+ T细胞相较于健康供者显著增加(分别为25%和26%,而健康供者为14%);然而,与健康供者相比,MGUS和MM患者中通过FOXP3表达测定的T(reg)细胞显著减少。此外,即使以更高比例添加,MM和MGUS患者的T(reg)细胞也无法抑制抗CD3介导的T细胞增殖。MGUS和MM中T(reg)细胞数量和功能的减少可能至少部分解释了CD4+ CD25+ T细胞的非特异性增加,从而导致T细胞反应功能失调。